Short Interest in NLS Pharmaceutics Ltd. (NASDAQ:NLSP) Rises By 52.3%

NLS Pharmaceutics Ltd. (NASDAQ:NLSP) was the target of a significant growth in short interest in February. As of February 15th, there was short interest totalling 169,500 shares, a growth of 52.3% from the January 31st total of 111,300 shares. Currently, 10.8% of the company’s shares are sold short. Based on an average daily trading volume, of 2,710,000 shares, the days-to-cover ratio is currently 0.1 days.

NLS Pharmaceutics Price Performance

Shares of NLSP stock traded down $0.18 on Tuesday, hitting $1.60. The stock had a trading volume of 82,899 shares, compared to its average volume of 3,493,938. The company’s 50 day moving average price is $2.06 and its 200-day moving average price is $2.36. NLS Pharmaceutics has a 1 year low of $1.47 and a 1 year high of $18.39.

About NLS Pharmaceutics

NLS Pharmaceutics AG, a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, such as attention deficit hyperactivity disorder (ADHD).